Vesper Ventures

Symbiomics is a biotechnology company dedicated to developing next-generation biological products that utilize robust-colonizing microbes to enhance plant growth. By integrating advanced sequencing technologies, machine learning, and genome editing tools, the company translates scientific knowledge into practical applications for agriculture and environmental sustainability. Symbiomics aims to improve plant performance while minimizing environmental impact, thereby enabling farmers to adopt sustainable agricultural practices through the use of organic products. With a commitment to innovation, Symbiomics strives to become a global leader in the biological market, offering solutions that contribute to both agricultural productivity and ecological health.

HapiSeeds is a technology company focused on sustainable agriculture. It develops innovative solutions to increase food production while minimizing environmental impact. The company's core business involves creating new commercial plant varieties through advanced plant engineering techniques, such as genome editing, and providing molecular tools to assist breeders and farmers. These technologies aim to enhance plant productivity, reduce the need for chemical fertilizers and irrigation, and improve disease resistance, ultimately promoting more efficient and sustainable agricultural practices.

Cellertz Bio is a biotechnology company focused on developing advanced cell therapies for cancer and other diseases. Utilizing an integrated in silico and experimental approach, the company aims to precisely control gene regulatory networks that define cell behaviors. By identifying and modulating specific genes, Cellertz Bio seeks to enhance cell therapies, contributing to potential advancements in healthcare. Their research efforts are geared towards improving the efficacy of cancer treatments and addressing various medical challenges through innovative biotechnology solutions.

Symbiomics is a biotechnology company dedicated to developing next-generation biological products that utilize robust-colonizing microbes to enhance plant growth. By integrating advanced sequencing technologies, machine learning, and genome editing tools, the company translates scientific knowledge into practical applications for agriculture and environmental sustainability. Symbiomics aims to improve plant performance while minimizing environmental impact, thereby enabling farmers to adopt sustainable agricultural practices through the use of organic products. With a commitment to innovation, Symbiomics strives to become a global leader in the biological market, offering solutions that contribute to both agricultural productivity and ecological health.

Symbiomics is a biotechnology company dedicated to developing next-generation biological products that utilize robust-colonizing microbes to enhance plant growth. By integrating advanced sequencing technologies, machine learning, and genome editing tools, the company translates scientific knowledge into practical applications for agriculture and environmental sustainability. Symbiomics aims to improve plant performance while minimizing environmental impact, thereby enabling farmers to adopt sustainable agricultural practices through the use of organic products. With a commitment to innovation, Symbiomics strives to become a global leader in the biological market, offering solutions that contribute to both agricultural productivity and ecological health.

InEdita Bio is a company focused on sustainable food production through its innovative plant genome editing platform. By making precise, minor modifications to the genetic code of crops, InEdita Bio aims to recover lost variability caused by traditional breeding methods. This approach enables the development of non-transgenic, nature-inspired crop varieties that are resistant to pests and diseases while enhancing their efficiency in water and nutrient use. The company's technology significantly reduces the reliance on chemical pesticides in food production, contributing to more sustainable agricultural practices.

Vyro Bio is a biotechnology company focused on immuno-oncology, specifically developing oncolytic viruses aimed at treating both adult and pediatric central nervous system tumors. The company leverages pioneering research into the oncolytic properties of the Zika Virus to create therapies that effectively target aggressive and fast-growing brain tumors. Through its innovative approach, Vyro Bio seeks to provide healthcare professionals with new treatment options for patients suffering from these challenging cancers.

Futr Bio is a biotechnology company dedicated to the development of mRNA vaccines aimed at preventing and curing diseases, including infections and cancer. The company has created innovative mRNA vaccine technologies that leverage natural untranslated regions (UTRs) and molecular boosters to enhance immune responses. This approach allows for the creation of single-dose vaccines that provide robust protective immunity for both humans and animals. By fine-tuning the control of the mammalian immune system, Futr Bio seeks to advance the field of immunization and contribute to global health initiatives.

Aptah Biosciences is a biotechnology company specializing in drug discovery. It uses a proprietary algorithm to streamline the drug development process, reducing time, costs, and risks associated with lead optimization and customization. Aptah's platform has successfully developed new molecules for cancer treatment, anti-inflammatory drugs, and gene therapy oligonucleotides. Its current focus is on developing an RNA therapy to target age-related diseases, with potential applications in neurodegenerative disorders and cancer, areas of significant unmet medical need and commercial potential.